ICD-10-CM Code L27.1

Localized skin eruption due to drugs and medicaments taken internally

Version 2020 Billable Code

Valid for Submission

L27.1 is a billable code used to specify a medical diagnosis of localized skin eruption due to drugs and medicaments taken internally. The code is valid for the year 2020 for the submission of HIPAA-covered transactions. The ICD-10-CM code L27.1 might also be used to specify conditions or terms like acneiform drug eruption, acneiform eruption, acneiform eruption due to chemical, adverse reaction to phenolphthalein, dermatitis due to drug and/or medicine taken internally, dermatitis due to substances taken internally, etc

ICD-10:L27.1
Short Description:Loc skin eruption due to drugs and meds taken internally
Long Description:Localized skin eruption due to drugs and medicaments taken internally

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code L27.1:

Use Additional Code

Use Additional Code
The “use additional code” indicates that a secondary code could be used to further specify the patient’s condition. This note is not mandatory and is only used if enough information is available to assign an additional code.
  • code for adverse effect, if applicable, to identify drug T36 T50

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code L27.1 are found in the index:


Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Acneiform drug eruption
  • Acneiform eruption
  • Acneiform eruption due to chemical
  • Adverse reaction to phenolphthalein
  • Dermatitis due to drug AND/OR medicine taken internally
  • Dermatitis due to substances taken internally
  • Drug-induced pseudolymphomatous eruption
  • Eczematous drug eruption
  • Fixed drug eruption
  • Fixed drug eruption due to phenolphthalein
  • Fixed drug reaction
  • Localized dermatitis caused by drug taken internally
  • Localized eczema due to systemically administered drug
  • Localized eruption of skin
  • Localized skin eruption caused by drug and medicament
  • Non-pigmenting fixed drug eruption

Diagnostic Related Groups

The ICD-10 code L27.1 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC).
applicable from 10/01/2019 through 09/30/2020.

  • 606 - MINOR SKIN DISORDERS WITH MCC
  • 607 - MINOR SKIN DISORDERS WITHOUT MCC

Convert L27.1 to ICD-9

  • 693.0 - Drug dermatitis NOS (Approximate Flag)

Code Classification

  • Diseases of the skin and subcutaneous tissue (L00–L99)
    • Dermatitis and eczema (L20-L30)
      • Dermatitis due to substances taken internally (L27)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020

Information for Patients


Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions.

One problem is interactions, which may occur between

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as ginkgo and blood thinners
  • Drugs and diseases, such as aspirin and peptic ulcers

Interactions can change the actions of one or both drugs. The drugs might not work, or you could get side effects.

Side effects are unwanted effects caused by the drugs. Most are mild, such as a stomach aches or drowsiness, and go away after you stop taking the drug. Others can be more serious.

Drug allergies are another type of reaction. They can be mild or life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is more rare.

When you start a new prescription or over-the-counter medication, make sure you understand how to take it correctly. Know which other medications and foods you need to avoid. Ask your health care provider or pharmacist if you have questions.


[Learn More]

Rashes

A rash is an area of irritated or swollen skin. Many rashes are itchy, red, painful, and irritated. Some rashes can also lead to blisters or patches of raw skin. Rashes are a symptom of many different medical problems. Other causes include irritating substances and allergies. Certain genes can make people more likely to get rashes.

Contact dermatitis is a common type of rash. It causes redness, itching, and sometimes small bumps. You get the rash where you have touched an irritant, such as a chemical, or something you are allergic to, like poison ivy.

Some rashes develop right away. Others form over several days. Although most rashes clear up fairly quickly, others are long-lasting and need long-term treatment.

Because rashes can be caused by many different things, it's important to figure out what kind you have before you treat it. If it is a bad rash, if it does not go away, or if you have other symptoms, you should see your health care provider. Treatments may include moisturizers, lotions, baths, cortisone creams that relieve swelling, and antihistamines, which relieve itching.


[Learn More]